Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

59
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
59
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

42
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
42

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative performance evaluation of machine learning classifiers for multi-class intrusion detection on the NSL-KDD dataset.

Scientific reports·2026
Same author

Identification and Computational validation of ferroptosis suppressor genes as therapeutic targets in pancreatic cancer.

Discover oncology·2026
Same author

Temporary Occipital Nerve Peripheral Nerve Stimulation at C2 in Refractory Occipital Pain: Case Series.

Pain medicine case reports·2026
Same author

Educational Background and Demographic Characteristics of Anesthesiology Department Chairs in the United States.

Anesthesiology open·2026
Same author

C8 Health, a Platform for the Implementation of Best Practices: Survey-Based Usability Study.

JMIR human factors·2026
Same author

Skeletal muscle mitochondrial bioenergetics in pregnancy: a comparison of in vivo and in vitro outcomes.

Journal of the Endocrine Society·2026

Related Experiment Video

Updated: Sep 15, 2025

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

2.8K

Transcatheter Aortic Valve Replacement (TAVR): A Comprehensive Descriptive Analysis.

Faria Nisar, Nicolas Mas D Alessandro, Alexander Estright

    Medrxiv : the Preprint Server for Health Sciences
    |July 17, 2025
    PubMed
    Summary

    Lower volume hospitals achieve TAVR outcomes similar to high-volume centers. This study shows quality care, not just size, drives success in transcatheter aortic valve replacement (TAVR).

    More Related Videos

    Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
    06:02

    Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

    Published on: August 8, 2025

    186
    Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
    06:59

    Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation

    Published on: June 3, 2018

    10.7K

    Related Experiment Videos

    Last Updated: Sep 15, 2025

    Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
    09:57

    Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

    Published on: January 20, 2022

    2.8K
    Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
    06:02

    Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

    Published on: August 8, 2025

    186
    Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
    06:59

    Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation

    Published on: June 3, 2018

    10.7K

    Area of Science:

    • Cardiovascular Medicine
    • Interventional Cardiology
    • Health Services Research

    Background:

    • Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive procedure for severe aortic stenosis, particularly for high-risk patients.
    • The increasing adoption of TAVR in lower-volume institutions raises questions about outcome comparability with established high-volume centers.

    Purpose of the Study:

    • To analyze procedural volume and patient outcomes for TAVR at a specific healthcare institution.
    • To compare institutional outcomes with results from the landmark PARTNER III trial.
    • To evaluate TAVR-related complications and assess patient selection criteria.

    Main Methods:

    • A retrospective descriptive study design was employed.
    • Data from 37 patients who underwent TAVR in 2022 at a public, multi-institutional healthcare system were analyzed.
    • Outcomes including mortality, readmission rates, and cardiovascular/cerebrovascular complications at 30 days and 1 year were collected and compared to the PARTNER III trial.

    Main Results:

    • No 30-day mortality was observed, contrasting with 1% in the PARTNER III trial.
    • The 1-year mortality rate was 2.7%, significantly lower than the 8.5% reported in the PARTNER III trial.
    • Zero patients experienced 30-day readmission for valve-related issues.

    Conclusions:

    • Lower-volume healthcare institutions can achieve TAVR outcomes comparable to higher-volume centers.
    • These findings challenge the notion that superior outcomes are solely dependent on institutional size.
    • Quality of care, teamwork, and individualized patient management are critical for excellent clinical outcomes in TAVR, irrespective of institutional volume.